Minnesota's Free Insulin Law Has 'Staggering' Implications, PhRMA Says
PhRMA sues to block implementation of the law, saying it could allow states to compel manufacturers to dispense other medications without compensation.
You may also be interested in...
Eighty-eight insurers who offer Medicare Part D plans are interested in the demonstration project, which would limit insulin copays to $35.
HHS lacks authority to require drug price disclosures in TV ads, judge rules. Even if legislation were to explicitly give the Trump Administration such authority, First Amendment issues would still linger.
Regulations allow manufacturers to request that drug production and marketing costs and price contracting information provided to the state be kept confidential.